ITC Feasibility Reporting Checklist
Defending your ITC for an EU Joint Clinical Assessment is less daunting when every expectation is mapped out. The ITC Feasibility Reporting Checklist helps your team align with Regulation (EU) 2021/2282, ensures high-quality reporting to justify your indirect treatment comparison (ITC), and promotes consistency across multiple internal stakeholders.
Without a clear structure, common pitfalls such as missing documentation of networks at the population and comparator levels, overlooked checks for heterogeneity, or failure to assess the proportional hazards assumption can lead to delays and undermine the credibility of your ITC submission to HTA bodies. This checklist brings these elements into focus early, enabling your team to address them confidently and efficiently.
What is included in this checklist :
Step-by-step reporting considerations for describing and evaluating your network of evidence
Key reporting items for assessing similarity across included trials
Guidance on selecting and justifying effect modifiers
Final justification requirements for your chosen ITC method
